Literature DB >> 18422579

Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone.

Masayuki Kobayashi1, Yukio Naya, Mika Kino, Yusuke Awa, Maki Nagata, Hiroyoshi Suzuki, Kunio Yamaguchi, Kuniyoshi Nozumi, Tomohiko Ichikawa.   

Abstract

OBJECTIVE: We evaluated the efficacy of low dose tamsulosin after extracorporeal shock wave lithotripsy (ESWL) in Japanese male patients with ureteral stone.
METHODS: One hundred and two Japanese male patients with ureteral stones who underwent ESWL were randomly divided into three groups. Group A (38 patients) was given tamsulosin (0.2 mg/day); group B (30 patients) was given c horeito, a herbal medicine (7.5 g/day); and group C (34 patients) received no medication. Stone clearance was assessed at 1, 7, 14, and 28 days after ESWL using plain abdominal radiography and abdominal ultrasonography. After 28 days, stone delivery was checked every 2 weeks.
RESULTS: The stone-free rate was 84.21%, 90%, and 88.24% for groups A, B, and C, respectively (P = 0.3425). The mean expulsion time was 15.66 +/- 6.14 days in group A, 27.74 +/- 25.36 days in group B, and 35.47 +/- 53.70 days in group C. The expulsion time of group A was significantly shorter than that of groups B (P = 0.0116) and C (P = 0.0424).
CONCLUSIONS: The addition of tamsulosin to conservative treatment appeared to be effective in shortening the stone expulsion time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422579     DOI: 10.1111/j.1442-2042.2008.02033.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  12 in total

1.  CUA Guideline: Management of ureteral calculi.

Authors:  Michael Ordon; Sero Andonian; Brian Blew; Trevor Schuler; Ben Chew; Kenneth T Pace
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

2.  [Urology update seminar UroUpdate. Düsseldorf 27th-28th February 2009].

Authors:  U Ayazpoor
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

3.  Does the use of doxazosin influence the success of SWL in the treatment of upper ureteral stones? A multicenter, prospective and randomized study.

Authors:  Ferhat Ateş; Bilal Eryıldırım; Metin Ishak Öztürk; Turgay Turan; Cenk Gürbüz; Mete Oğuz Ekinci; Asıf Yıldırım; Cemal Göktaş; Temuçin Şenkul; Kemal Sarıca
Journal:  Urol Res       Date:  2012-01-07

4.  Optimizing shock wave lithotripsy: a comprehensive review.

Authors:  Paul D McClain; Jessica N Lange; Dean G Assimos
Journal:  Rev Urol       Date:  2013

5.  Adjunctive medical therapy with α-blocker after extracorporeal shock wave lithotripsy of renal and ureteral stones: a meta-analysis.

Authors:  Mingchao Li; Zhengyun Wang; Jun Yang; Xiaolin Guo; Tao Wang; Shaogang Wang; Chunping Yin; Jihong Liu; Zhangqun Ye
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

6.  A network meta-analysis on the beneficial effect of medical expulsive therapy after extracorporeal shock wave lithotripsy.

Authors:  Tong-Xin Yang; Bang-Hua Liao; Yun-Tian Chen; Hong Li; Qing He; Qin-Yu Liu; Kun-Jie Wang
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

7.  Impact of tamsulosin on ureter stone expulsion in korean patients: a meta-analysis of randomized controlled studies.

Authors:  Jung Keun Lee; Chang Wook Jeong; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  Korean J Urol       Date:  2012-10-19

8.  Efficacy of alfuzosin after shock wave lithotripsy for the treatment of ureteral calculi.

Authors:  Hee Ju Cho; Soon Cheol Shin; Do Young Seo; Dong Suk Min; Jeong Man Cho; Jung Yoon Kang; Tag Keun Yoo
Journal:  Korean J Urol       Date:  2013-02-18

9.  The efficacy of tamsulosin therapy after extracorporeal shock-wave lithotripsy for ureteric calculi: A prospective randomised, controlled study.

Authors:  Hassan Ismail Mohamed
Journal:  Arab J Urol       Date:  2013-09-29

10.  Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.

Authors:  Makinna C Oestreich; Robin Wm Vernooij; Niranjan J Sathianathen; Eu Chang Hwang; Gretchen M Kuntz; Alex Koziarz; Charles D Scales; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2020-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.